Chloroquine enhances replication of influenza A virus A/WSN/33 (H1N1) in dose-, time-, and MOI-dependent manners in human lung epithelial cells A549

J Med Virol. 2015 Jul;87(7):1096-103. doi: 10.1002/jmv.24135. Epub 2015 Feb 25.

Abstract

Anti-malaria drug, chloroquine, has been reported to be effective against influenza A virus (IAV) in vitro and used in in-vivo experiments and clinical trial for prevention or treatment of influenza. In this study, it has been shown by immunofluorescence, hemagglutination, and plaque assays that chloroquine enhanced A/WSN/33 (H1N1) replication with pronounced cytopathic effect in dose-, time-, and MOI-dependent manners in human lung epithelial cells A549. Time-of-addition assay showed that inhibitory effect on virus replication by chloroquine pre-treatment was indistinctive, and virus productions were enhanced when the drug was applied after viral adsorption. The effectiveness of chloroquine as an anti-influenza drug is questioned, and caution in its use is recommended.

Keywords: A549; WSN; chloroquine; influenza A virus; replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / pharmacology
  • Antiviral Agents / pharmacology
  • Cell Line, Tumor
  • Cells, Cultured
  • Chloroquine / pharmacology*
  • Cytopathogenic Effect, Viral / drug effects
  • Dose-Response Relationship, Drug
  • Epithelial Cells / virology
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / physiology*
  • Time Factors
  • Virus Replication / drug effects*

Substances

  • Antimalarials
  • Antiviral Agents
  • Chloroquine